Home Blog Page 1801

The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery — From Sabah to the Super Bowl

By
Advertorial Desk
-

KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ — Big changes often start in small ways. For Sabah FC, a top Malaysian football club, it began with a simple agreement — a partnership with European Wellness, a medical group best known for anti-aging and precursor stem cell therapy.

Officials from European Wellness and Sabah FC: (Pictured, from left) Dr. Natassia Sarah, Prof. Mike Chan, Tuan Md Joh Haji Wid, and Tuan Shamsuddin Bin Mohd Shah — exchange club jerseys in a symbolic gesture marking their newly formalized partnership for athlete rehabilitation and sports-science collaboration.
Officials from European Wellness and Sabah FC: (Pictured, from left) Dr. Natassia Sarah, Prof. Mike Chan, Tuan Md Joh Haji Wid, and Tuan Shamsuddin Bin Mohd Shah — exchange club jerseys in a symbolic gesture marking their newly formalized partnership for athlete rehabilitation and sports-science collaboration.

But that one move is now shaking up the world of sports medicine.

Because what started in Sabah is now heading to the biggest sporting stage in the world: the Super Bowl.

And behind it all is a man who’s been preparing for this moment for over 40 years — Prof. Dato’ Sri Dr. Mike Chan.

How It All Started in Sabah

In late 2025, Sabah FC signed a deal with European Wellness Premier Center (EWPC) in Kota Kinabalu, Sabah. Their goal? To help players recover faster, avoid injuries, and stay at their best throughout the season — not just with physical therapy, but by treating their whole body from the inside out.

The club became the first in Malaysia to bring in bioregenerative medicine — a medical approach that focuses on healing, restoring, and rebuilding the body at the cellular level.

Sabah FC’s General Manager, Md Joh Wid, put it simply:
 “We want our players to come in good condition and leave in good condition.”

Prof. Mike Chan added:
 “Real endurance isn’t just about stamina. It’s about staying strong — even in extra time.”

What the Players Actually Get

This isn’t just about vitamins or spa treatments. Sabah FC players now undergo a special 4-step program: Diagnose, Detox, Repair, Rejuvenate.

Here’s what that means in plain terms:

  • Players get a full health check to spot issues early
  • They flush out harmful toxins that slow down recovery
  • They receive treatments to help damaged muscles and organs heal faster
  • Finally, they boost their energy, focus, and strength from within — often using safe, natural therapies like oxygen treatments and nutritional support

Why It Works

Regular training and rehab treat what you can see: sore muscles, swelling, maybe a twisted ankle. But what about the stuff you can’t see — like tired organs, stress hormones, or long-term wear and tear?

That’s where Prof. Chan’s method comes in. It’s used by celebrities, high-level executives, and now — footballers.

His treatments help with:

  • Fatigue
  • Recovery time
  • Mental sharpness
  • Joint strength
  • Even hormonal balance

And the best part? It’s tailored to each athlete’s body — no one-size-fits-all.

The Super Bowl Invitation

Just as the Sabah FC partnership was gaining attention, Prof. Chan got a call from the U.S. — from Leigh Steinberg, the famous NFL agent who inspired the movie, Jerry Maguire.

Steinberg invited Prof. Chan to speak during Super Bowl Week 2026, in front of NFL teams, doctors, and athletes. Why? Because the NFL is looking for real solutions to a major problem: concussions and brain injuries.

Prof. Chan has spent years working on brain-specific treatments — using safe, organ-targeted cell therapy to help people with memory loss, autism, and yes, sports-related brain damage.

As he explains:
 “You can’t treat all injuries with the same solution. A knee needs knee treatment. A brain needs brain therapy. Precision matters.”

What It Means for Sports in 2026

This is just the beginning.

Thanks to Sabah FC, Southeast Asia is now leading the way in next-gen athlete care. And with the Super Bowl platform, the rest of the world is starting to pay attention.

Other sports may soon follow — including rugby, MMA, and Olympic teams — all exploring new ways to keep their athletes strong, focused, and injury-free for longer.

Prof. Chan’s premier center in Kota Kinabalu is now being called ASEAN’s hub for elite athlete regeneration.

Looking Ahead

2025 was the start.
2026 could be the global breakthrough.

The science is ready. The results are promising. And the sports world is finally open to new ideas.

Athletes deserve better than rest and painkillers. They deserve real recovery.
And thanks to Prof. Mike Chan — that’s exactly what they’re starting to get.

Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia’s Fight Against Autism

By
Advertorial Desk
-

KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ — Malaysia’s drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen Akashah Khalil, attended the International Congress on Advances in Autism, Neurodevelopmental & Neurodegenerative Disorders (ICAANND 2025) in Kuala Lumpur. Their appearance signalled rising national commitment to early diagnosis, intervention capacity and improved support for neurodiverse families. ICAANND 2025 was organized by the European Wellness Biomedical Group (EWBG). 

Prof. Dato’ Sri Dr. Mike Chan and the ICAANND 2025 international faculty stand alongside the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Ibni Tuanku Syed Sirajuddin Jamalullail and Raja Puan Muda, Tuanku Dr. Hajah Lailatul Shahreen Akashah binti Khalil during a special appreciation segment honouring speakers at Glamhall, Damansara.
Prof. Dato’ Sri Dr. Mike Chan and the ICAANND 2025 international faculty stand alongside the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Ibni Tuanku Syed Sirajuddin Jamalullail and Raja Puan Muda, Tuanku Dr. Hajah Lailatul Shahreen Akashah binti Khalil during a special appreciation segment honouring speakers at Glamhall, Damansara.

The royal presence aligned with the scientific direction championed by Prof. Dato’ Sri Dr. Mike Chan, whose two decades of global research have positioned him as one of Asia’s leading voices in precision neuro-generation.

Rising Needs in Malaysia

Perlis, like many parts of the country, has seen an increase in autism prevalence among school-aged children. Through UniMAP and the A-HEART Autism Hub, the Perlis royal household has invested in early identification, teacher training and family support programs. Their visit in Kuala Lumpur highlighted the need to extend such efforts nationally.

Prof. Mike Chan’s Global Autism Mission

Prof. Chan’s work on autism began more than a decade ago in Baoding, China, where he trained paediatric teams to improve diagnostic accuracy and early detection. These early initiatives helped shape his long-term approach to neurodevelopmental conditions.

His wellness centers have consistently documented two major biological patterns among autistic children: severe gut dysfunction and heavy-metal accumulation. “Your gut has more brain cells than your brain. If you do not fix the gut, you cannot fix the child,” Prof. Chan told delegates at the Bangkok Summit.

His model of care is built on precision. It combines intestinal mucosa precursors with brain-region-specific support to target key areas such as the frontal lobe, hippocampus and cortex. This organ-specific strategy parallels the scientific work published in his Human Cytology Atlas, which maps more than 400 human cell types.

A Turning Point in the United States

In April 2025, Prof. Chan presented at the Autism Summit in San Diego, where United States presidential candidate Robert F. Kennedy Jr. pledged to “find an answer for autism by September.” The event drew global attention and intensified discussions on early intervention and scientific pathways.

At the summit, Prof. Chan emphasized that autism cannot be treated with generic or broad-spectrum approaches. He stressed that each organ and brain region require specific precursor support and that the future of autism care lies in precision, early detection and environmental correction.

Royal Recognition in Kuala Lumpur

In Kuala Lumpur, Prof. Chan presented an Appreciation Plaque to the Raja Muda of Perlis in recognition of the royal household’s dedication to autism advocacy. Although their visit was brief, it carried national significance and underscored growing unity between scientific leadership and state-level action.

“We saw the passion of the Perlis royal household first hand,” Prof. Chan said. “They care deeply about children, families and the future of autism services in Malaysia.”

Malaysia’s Path Forward

With scientific frameworks refined in Baoding, amplified in San Diego and Bangkok, and supported by Malaysian royalty, Prof. Chan says Malaysia is entering a critical new phase. The country is increasingly positioned to lead regional efforts in advanced autism intervention and neurodevelopmental research.

“No child should be left behind,” he said. “Every family deserves access to proper autism support, no matter where they live.”

As Malaysia aligns scientific capability, leadership and public awareness, its role in the global autism movement continues to grow.

Media Contact: 

Justin Chew & Gerald Chuah
Media Team
media@european-wellness.com 

Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

By
Advertorial Desk
-

–  Utilizing Ascletis’ Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9–, 30–, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to-head non-human primate (NHP) studies.

–  ASC37 oral tablets’ drug exposure, as measured by the area under curve (AUC), was approximately 57-fold of retatrutide’s drug exposure in head-to-head NHP studies.

–  Average observed half-life of ASC37 oral tablets was approximately 56 hours in NHP studies, supporting once daily and less frequent oral dosing.

–  ASC37 in vitro activity was approximately 5-, 4- and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.

–  Submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC37 oral tablets is expected in the second quarter of 2026.

–  The Company will host a conference call in Mandarin at 10:00 a.m. China Standard Time on December 1, 2025.

HONG KONG, Nov. 30, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that it has selected ASC37 oral tablets, its first oral GLP-1R/GIPR/GCGR[1] triple peptide agonist, as a clinical development candidate. Ascletis expects to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC37 oral tablets for the treatment of obesity in the second quarter of 2026.

ASC37 oral tablets is the Company’s first incretin drug candidate developed with its proprietary Peptide Oral Transport ENhancement Technology (POTENT). 

ASC37, a GLP-1R, GIPR, and GCGR triple peptide agonist, was discovered and optimized in-house utilizing Ascletis’ Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD). ASC37 in vitro activity was approximately 5-, 4-, and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.

Utilizing Ascletis’ POTENT technology, ASC37 oral tablets achieved average absolute oral bioavailability[2] of 4.2%, which was approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC [3] formulation, respectively, in head-to-head non-human primate (NHP) studies. Furthermore, after oral administration, ASC37 oral tablets’ drug exposure, as measured by the area under curve (AUC), with the POTENT formulation was approximately 57-fold of retatrutide’s drug exposure with the oral SNAC formulation, in head-to-head NHP studies.

Average observed half-life of ASC37 oral tablets was approximately 56 hours in NHP studies, supporting once daily and less frequent oral dosing.

 “Selection of ASC37, a promising oral GLP-1R/GIPR/GCGR triple peptide agonist, for clinical development once again demonstrates our strong R&D capabilities and our commitment to address the unmet needs for the treatment of obesity,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, “Leveraging our proprietary technology platforms, including AISBDD and POTENT, Ascletis has successfully established a highly competitive, differentiated and diverse pipeline portfolio which can potentially effectively address the various treatment needs of patients with obesity and other metabolic diseases.”

[1] GLP-1R: glucagon-like peptide 1 receptor, GIPR: gastric inhibitory polypeptide receptor, GCGR: glucagon receptor

[2] absolute oral bioavailability: the percentage of an orally administered drug that reaches the systemic circulation (bloodstream), compared to an intravenous (IV) dose of the same drug

[3] SNAC: Salcaprozate Sodium

Conference Call

Ascletis will host a conference call in Mandarin at 10:00 a.m. China Standard Time on December 1, 2025. A live webcast of the call will be available via Tencent Meeting/ VooV Meeting, with the Meeting ID: 495-266-842, or access links of:

Chinese Mainland: https://meeting.tencent.com/dm/10ve6whW8Rbl; or

International: https://voovmeeting.com/dm/10ve6whW8Rbl.

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, an oral GLP-1R/GIPR/GCGR triple peptide agonist for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

For more information, please visit www.ascletis.com.

Contact：

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com 

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com 

Xinhua Silk Road: Discover China with foreign friends

By
Advertorial Desk
-

BEIJING, Nov. 30, 2025 /PRNewswire/ — Do you want to visit China? How to travel as convenient as a local resident? You can learn from this guide! There are three foreign residents from different countries to show you the mobile payments, transportation and local cuisine. Come and get the shortcut!

 

Original link: https://en.imsilkroad.com/p/348542.html

Thailand, Indonesia Begin Clean-up After Massive Floods Kill Hundreds

By
Phontham Visapra
-
Thailand, Indonesia Begin Clean-up After Massive Floods Kill Hundreds
Tens of thousands of people in Thailand and neighbouring Malaysia were displaced by widespread flooding, with streets submerged, homes inundated and at least 34 dead, officials said November 26. Photo by HANDOUT / 4TH ARMY REGION OF THE ROYAL THAI ARMY / AFP

By Alfath Asmunda/AFP – The death toll from devastating floods and landslides in Southeast Asia climbed past 400 on Saturday as clean-up and search-and-rescue operations got underway in Indonesia, Thailand, and Malaysia.

Continue

Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery

By
Advertorial Desk
-

SHANGHAI, Nov. 30, 2025 /PRNewswire/ — On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, on November 28, Qiming Venture Partners made a donation of HK$3 million to the Tai Po Wang Fuk Court Aid Fund established by the Hong Kong SAR Government, to support affected residents and contribute to post-disaster reconstruction.

The Hong Kong SAR Government established the Tai Po Wang Fuk Court Aid Fund on November 27, with an initial allocation of HK$300 million, to coordinate social resources and fully carry out rescue and recovery support. The fund is also open to donations from the public, aiming to unite support from all walks of life to facilitate efficient aid distribution. Qiming Venture Partners responded promptly with this donation, to assist those affected while fulfilling its corporate social responsibility.

Qiming Venture Partners expresses our condolences to the families impacted by the major fire, and our deepest respect to the firefighters and rescue personnel at the frontline. We are grateful for their exceptional professionalism and selfless dedication which were evident throughout the crisis. Qiming hopes that its contribution will help alleviate the challenges faced by affected residents and support their swift return to normal life. Qiming also calls on more social forces to join in the relief efforts and contribute to the rebuilding of the affected communities.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, zai, StepFun, among many others.

VEVOR Powers Black Friday Growth and Lights Up Times Square with Immersive Pop-Up

By
Advertorial Desk
-

NEW YORK, Nov. 30, 2025 /PRNewswire/ — Global home improvement brand VEVOR closed out Black Friday with strong commercial momentum and a high-profile brand activation in New York’s Times Square, reinforcing its commitment to supporting creators in the home improvement and maker economy worldwide. Through a large-scale public installation and sustainability-driven pop-up experience, the brand brought its “Upgrade Every Space” philosophy to life in one of the world’s most iconic urban spaces.

VEVOR Pop-Up:"The Great Upgrade"
VEVOR Pop-Up:”The Great Upgrade”

Strong Business Growth Fueling the Creator Economy

This year’s Black Friday marked another milestone for VEVOR, with strong year-on-year growth, reflecting increased demand from Home Creators engaging in DIY, home maintenance, and maker-style projects.

Among standout products, the VEVOR Mechanics Stool proved a favorite for hands-on projects, offering a sturdy and comfortable seat for automotive repairs, furniture assembly, and other practical tasks; the VEVOR Impact Socket Set became one of the most sought-after solutions for DIY and automotive work, delivering high strength and versatility; and the VEVOR Mechanics Tool Set and Socket Set served as a go-to kit for a wide range of home and workshop projects, trusted for its comprehensive coverage and reliable performance.

With professional-grade quality, reliable performance, and accessible pricing, VEVOR continues to strengthen its position as a trusted home improvement solutions partner, supporting creators across diverse projects and everyday hands-on scenarios.

VEVOR Pop-Up:"The Great Upgrade"
VEVOR Pop-Up:”The Great Upgrade”

VEVOR Brings Creativity, Sustainability, and Community to Times Square

VEVOR successfully staged “The Great Upgrade” in New York’s Times Square, an innovative pop-up experience that brought its philosophy, “Upgrade Every Space,” to life through hands-on participation. The event revolved around three core initiatives — trade-up of old items, eco-friendly art, and the Home Creator Fund — creating a meaningful platform for creativity, sustainability, and community engagement. Over thousands Home Creators brought their idle tools and household items, exchanging them for exclusive $9.9 new product trade-up vouchers. The activation showcased how thoughtful innovation and sustainable practices can transform everyday spaces while fostering a vibrant, connected community.

As part of the activation, VEVOR collaborated with Brooklyn-based public artist Tom Fruin to create HOUSE, a large-scale sculpture made from reclaimed materials. Attendees joined Fruin in assembling and shaping the installation, experiencing firsthand the excitement of hands-on creativity and collaborative art-making. The interactive project reflected VEVOR’s vision of empowering Home Creators to transform everyday spaces through imagination, sustainability, and shared experiences.

VEVOR Pop-Up:"The Great Upgrade"
VEVOR Pop-Up:”The Great Upgrade”

“I love transforming ordinary, discarded materials into something that captures light and imagination. Collaborating with VEVOR allowed us to show how creativity and sustainability can meet in everyday spaces,” said Tom Fruin.

“Being able to trade items I no longer use and see them transformed into art was incredible. It made me feel part of a truly creative and sustainable community,” said Jessica Lee, a Brooklyn resident and DIY enthusiast who participated in the event.

During the activation, VEVOR also announced the launch of the VEVOR Home Creator Fund, a long-term initiative supporting community organizations, sustainability projects, and home improvement programs. The fund extends the impact beyond a single event while reinforcing the company’s commitment to fostering lasting, community-driven change.

Building a Creator-Centered Brand with Purpose

With a global user base exceeding 20 million, VEVOR remains focused on enabling people to improve their living and working environments. From professional tradespeople and DIY enthusiasts to micro-entrepreneurs and makers, VEVOR is building a creator-driven ecosystem rooted in empowerment and accessibility.

By investing in durable products, localized service networks, and meaningful social impact initiatives, VEVOR continues to balance rapid growth with long-term responsibility. Looking ahead, the company will further support creators worldwide — making creativity a catalyst for stronger communities and more vibrant cities.

 

Democratizing Solar Power: Skyworth PV Launches Home Solar 2.0 in Vietnam

By
Advertorial Desk
-

HO CHI MINH CITY, Vietnam, Nov. 29, 2025 /PRNewswire/ — A seminar on renewable energy and energy storage applications was held on November 28 in Ho Chi Minh City, Vietnam. The event fostered substantive discussions on next-generation solar systems, the strategic value of battery energy storage systems (BESS) in the energy transition, evolving two-part tariff structures, and targeted, forward-looking investment solutions. More than 100 attendees from industry associations, leading companies, and ecosystem partners joined the session to shape the future of clean energy in Vietnam. 

Seizing Opportunities, Ushering in a New Era for Residential Solar

In a keynote address, Ms. Shen Lu, national general distributor for Shenzhen Skyworth Photovoltaic Technology Co., Ltd. (“Skyworth PV”) in Vietnam, delivered a comprehensive analysis of the current landscape and future trajectory of Vietnam’s residential solar market. She emphasized Vietnam’s exceptional solar energy resources, noting an average annual sunlight exceeding 2,000 hours, which provides a natural foundation for solar power generation. At present, however, PV applications are mostly seen in large ground-mounted power stations and commercial or industrial rooftop systems, with relatively limited adoption among ordinary households.

Simplifying Complexity, Redefining Home Solar

To address these market gaps, Skyworth PV announced the official launch of its SUN Mate Home Solar 2.0 solution, the result of extensive market research and technological innovation. The core proposition of this new offering is “making clean energy accessible,” effectively transforming complex solar power generation into a product as straightforward and user-friendly as a standard household appliance. 

A defining feature of the SUN Mate series is its “plug-and-play” design. Unlike conventional solar installations that require professional design, complex construction, and structural modifications, SUN Mate truly achieves a “three no” principle: no design, no construction, and no modification needed. Homeowners are freed from concerns about complex installation requirements; whether for urban apartment balconies or rural home courtyards, a suitable and simple installation solution is readily available.

In everyday use, SUN Mate delivers equally impressive performance. The system produces power during daylight hours for direct household consumption, significantly cutting grid electricity usage and cost. Through Skyworth’s proprietary smart cloud platform and mobile app, users can monitor real-time generation data and equipment status, and connect with professional customer service when needed. This intelligent management experience—making solar energy “visible, manageable, and affordable”—enables households to adopt solar power effortlessly. 

Versatile Designs for Vietnamese Homes

To enable broader clean energy adoption across Vietnamese households, Skyworth PV has engineered three distinct SUN Mate product configurations, each meticulously optimized for specific settings.

The Balcony Model fits modern urban living. Its compact structure and minimalist design enable seamless integration with various architectural styles. The unique bracket-based setup requires no special tools and preserves building structures, making installation possible even for apartment dwellers. Designed to withstand Vietnam’s rainy and windy seasons, the model offers enhanced stability to maintain safety and reliability in adverse weather conditions.

The Awning Model strategically combines power generation with practical shade provision, making it particularly suitable for storefronts or the exteriors of owner-built houses. It not only supplies electricity and cuts energy costs, but also creates comfortable shaded spaces, delivering multiple functional benefits. Its stylish design also enhances a building’s visual appeal.

The Ground Model has drawn widespread attention for its superior adaptability. It supports angle adjustments between 25 and 40 degrees, allowing users to easily position it for optimal power generation based on seasonal variations and sun angles. Suitable for family yards, terraces, or campsites, the unit can also be folded and relocated with ease—bringing portable clean energy wherever needed. 

As awareness of clean energy grows and technology continues advancing, residential solar power is transitioning from a premium alternative to an essential household solution. Through its innovative products and user-centered design, Skyworth PV is opening the door to the clean energy era for Vietnamese households. On this path toward sustainability, Skyworth PV remains committed to partnering with families across Vietnam to collectively build a cleaner, more promising future.

1...1,8001,8011,802...6,610Page 1,801 of 6,610